Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:293-294 (5 August), doi:10.1136/bmj.333.7562.293
Kalyan Kumar Gangopadhyay, specialist registrar in diabetes and endocrinology1, Francis Sundram, specialist registrar2, Parijat De, consultant in medicine, diabetes, and endocrinology1
1 Department of Medicine, Diabetes, and Endocrinology, City Hospital, Birmingham B18 7QH, 2 Department of Nuclear Medicine, City Hospital, Birmingham
Correspondence to: K K Gangopadhyay, 87 Thorncroft Way, Walsall WS5 4EF jaykal69@hotmail.com
| The first 150 words of the full text of this article appear below. |
Increasing numbers of diagnostic and therapeutic procedures involving radioisotopes are being conducted. The most common procedures include thallium scans for myocardial perfusion, ventilation perfusion lung scans, bone scans, iodine uptake scans, and radioactive iodine as treatment for thyroid disorders. For thyrotoxicosis, for example, 10 000 patients received radioactive iodine (131I) treatment in one year in the United Kingdom alone.1
Such procedures make patients temporarily radioactive and can be an important cause of false alarms at airports by activating radiation detectors. Doctors show a worrying lack of awareness about such potential problems. As a result, patients receiving radioactive isotopes for diagnostic and therapeutic purposes are not adequately warned about persisting radioactivity and precautions that need to be taken.2 We report a case that further highlights this problem.
A 46 year old man was referred to our endocrine clinic in July 2003 with a history of weight loss, sweating, and diarrhoea.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses